Merck to buy Idenix Pharmaceuticals for $3.85B By: Philadelphia Business Journal via Business Journals June 09, 2014 at 09:37 AM EDT Merck, in a move to expand its portfolio of hepatitis C treatments, has entered into a deal to acquire Idenix Pharmaceuticals Inc... Read More >>